This announcement is a separate document:
达嘉维康：关于收购湖南天济草堂制药股份有限公司85.7143%股份的补充公告
Dajia Weikang: Supplemental Announcement on Acquisition of 85.7143% of Hunan Tianji Caotang Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.